10x Genomics, Inc. (TXG) stock analysis
TXG · 10x Genomics, Inc.
Latest recorded price: USD 54.99
Sector and industry: Healthcare · Medical Devices
Fiscal 2025 figures: revenue growth 7.6%, free cash flow margin 20.2%, ROIC -21.8%. The model flags 1 risk signal for this company.